Eva
Fernández Rodríguez
Universidade de Santiago de Compostela
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (14)
2023
-
GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain
Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 1, pp. 29-38
2021
-
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas
Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819
2019
-
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly
EBioMedicine, Vol. 43, pp. 537-552
2015
-
Hypopituitarism After Traumatic Brain Injury
Endocrinology and Metabolism Clinics of North America, Vol. 44, Núm. 1, pp. 151-159
-
Update on prognostic factors in acromegaly: Is a risk score possible?
Pituitary, Vol. 18, Núm. 3, pp. 431-440
2013
-
Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients
Clinical Endocrinology, Vol. 78, Núm. 2, pp. 278-284
-
Signs and Symptoms of Pituitary Disease
Pituitary Disorders: Diagnosis and Management (Wiley-Blackwell), pp. 13-20
2012
-
Adenomas hipofisarios no funcionantes
Medicine (Spain), Vol. 11, Núm. 13, pp. 757-763
2011
-
Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: Prevalence, evolution of hormone dysfunction and genetic analysis
Neuroendocrinology, Vol. 93, Núm. 3, pp. 181-188
-
Somatotroph tumor progression during pegvisomant therapy: A clinical and molecular study
Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 2
2010
-
Hypopituitarism following traumatic brain injury: Determining factors for diagnosis
Frontiers in Endocrinology, Vol. 2, Núm. AUG
-
Pegvisomant-induced liver injury is related to the UGT1A1*28 polymorphism of Gilbert's syndrome
Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 5, pp. 2147-2154
-
The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly
Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 1, pp. 222-229
2008
-
Severe hypertension and hypokalemia as first clinical manifestations in ectopic Cushing's syndrome
Arquivos Brasileiros de Endocrinologia e Metabologia, Vol. 52, Núm. 6, pp. 1066-1070